Bjorn Voldborg

Mr. Voldborg has more than 20 years of experience in expression and production of recombinant proteins for research and therapy, from both academic and industrial settings. From 2001 to 2009, Bjørn Voldborg was team leader in the Danish biotech company Pharmexa A/S, responsible for molecular cloning and expression of protein based drug candidates, for active immunotherapy.

From this he went to the NNF Center for Protein Research at the University of Copenhagen as Head of the Protein Production Unit, and since 2012 Bjørn Voldborg has been heading the CHO Cell Line Engineering research at the Technical University of Denmark, by running a program dedicated to the engineering of improved CHO based cell factories for recombinant protein production. As a frequently invited speaker, chairman and panelist, Bjørn Voldborg is a very well-known and highly respected scientist within the field, and he has a deep understanding of R&D challenges and requirements needed, for bringing new protein based therapeutics forward.